↓ Skip to main content

The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country

Overview of attention for article published in HEPAC Health Economics in Prevention and Care, July 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country
Published in
HEPAC Health Economics in Prevention and Care, July 2012
DOI 10.1007/s10198-012-0413-8
Pubmed ID
Authors

Mehlika Toy, Fatih Oguz Onder, Ramazan Idilman, Gokhan Kabacam, Jan Hendrik Richardus, Mithat Bozdayi, Meral Akdogan, Zarife Kuloglu, Aydan Kansu, Solko Schalm, Cihan Yurdaydin

Abstract

Chronic hepatitis B (CHB) infection is a serious public health problem due to its potential liver disease sequelae and highly expensive medical costs such as the need for liver transplantation. The aim of this study was to quantify the burden of active CHB in terms of mortality and morbidity, the eligibility of antiviral treatment and to assess various treatment scenarios and possible salvage combinations for cost-effectiveness.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 2%
Unknown 56 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 19%
Student > Ph. D. Student 9 16%
Student > Master 8 14%
Student > Postgraduate 5 9%
Other 4 7%
Other 8 14%
Unknown 12 21%
Readers by discipline Count As %
Medicine and Dentistry 20 35%
Economics, Econometrics and Finance 7 12%
Social Sciences 6 11%
Nursing and Health Professions 2 4%
Agricultural and Biological Sciences 2 4%
Other 6 11%
Unknown 14 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2018.
All research outputs
#7,955,699
of 25,838,141 outputs
Outputs from HEPAC Health Economics in Prevention and Care
#524
of 1,316 outputs
Outputs of similar age
#54,417
of 178,787 outputs
Outputs of similar age from HEPAC Health Economics in Prevention and Care
#5
of 6 outputs
Altmetric has tracked 25,838,141 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,316 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 178,787 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.